TY  - JOUR
AU  - Gago-Veiga, A B
AU  - Santos-Lasaosa, S
AU  - Cuadrado, M L
AU  - Guerrero, Á L
AU  - Irimia, P
AU  - Láinez, J M
AU  - Leira, R
AU  - Pascual, J
AU  - Sanchez Del Río, M
AU  - Viguera, J
AU  - Pozo-Rosich, P
PY  - 2017
DO  - 10.1016/j.nrl.2017.09.008
UR  - http://hdl.handle.net/10668/11841
T2  - Neurologia (Barcelona, Spain)
AB  - OnabotulinumtoxinA has been demonstrated to be effective as a preventive treatment in patients with chronic migraine (CM). Five years after the approval of onabotulinumtoxinA in Spain, the Headache Study Group of the Spanish Society of Neurology...
LA  - en
KW  - Botulinum neurotoxin A
KW  - Chronic migraine
KW  - Consenso
KW  - Consensus
KW  - Guidelines
KW  - Migraña crónica
KW  - OnabotulinumtoxinA
KW  - Preventive treatment
KW  - Recomendaciones
KW  - Toxina botulínica A
KW  - Tratamiento preventivo
KW  - Botulinum Toxins, Type A
KW  - Guidelines as Topic
KW  - Humans
KW  - Migraine Disorders
KW  - Neurologists
KW  - Spain
TI  - Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice.
T2  - Evidencia y experiencia de bótox en migraña crónica: Recomendaciones para la práctica clínica diaria.
TY  - research article
VL  - 34
ER  -